That’s according to a report from FOX News.
The company hopes that will happen by fall of this year.
Pfizer currently has approval for vaccinate 12 and up with its vaccine.
The dosages for children in the younger group would be lower.
Pfizer trials have included ages 6 months to 11 years old.